IP Library Granted Patent US 7,517,863
Granted Patent B2
US 7,517,863 · App. 11/034,682 · Granted Apr 14, 2009

Enhanced secretion/retention of growth hormone releasing hormone (GHRH) from muscle cells by species-specific signal peptide

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,517,863
App. No.
11/034,682
Granted
Apr 14, 2009
Kind
B2
Abstract

One aspect of the current invention is a method designing and using species-specific or synthetic signal peptides and GHRH sequences for the purpose of preventing and/or treating chronic illness in a subject by utilizing methodology that administers a single dose of nucleic acid expression vector or nucleic acid expression construct encoding a GHRH or functional biological equivalent to a subject through a parenteral route of administration.

Claims (19)

1. A method of expressing and secreting an encoded growth-hormone-releasing-hormone (“GHRH”) peptide from a cell of a subject comprising; delivering into the cell of the subject an isolated nucleic acid expression construct that comprises a promoter operatively linked to a nucleic acid sequence encoding a signal peptide coupled to the encoded GHRH peptide, wherein the encoded signal peptide has the amino acid sequence of SEQ ID NO:51 and the encoded GHRH has the amino acid sequence of SEQ ID NO:10, wherein the delivering into the cell of the subject the nucleic acid expression construct initiates expression of the encoded signal peptide and GHRH.

2. The method of claim 1 , wherein delivering comprises: an electroporation method in conjunction with a carrier.

3. The method of claim 2 , wherein the electroporation method comprises:

a. penetrating a tissue in the subject with a plurality of needle electrodes, wherein the plurality of needle electrodes are arranged in a spaced relationship;

b. introducing the nucleic acid expression construct into the tissue between the plurality of needle electrodes; and

c. applying an electrical pulse to the plurality of needle electrodes.

4. The method of claim 3 , wherein the nucleic acid expression construct is delivered in a single dose.

5. The method of claim 4 , wherein the single dose comprises about a 0.01-10 mg quantity of nucleic acid expression construct.

6. The method of claim 2 , wherein the carrier further comprises, a transfection-facilitating polypeptide.

7. The method of claim 6 , wherein the transfection-facilitating polypeptide comprises a charged polypeptide.

8. The method of claim 7 , wherein the transfection-facilitating polypeptide comprises poly-L-glutamate.

9. The method of claim 1 , wherein the cell of the subject comprise diploid cells.

10. The method of claim 1 , wherein the cell of the subject comprise muscle cells.

11. The method of claim 1 , wherein the subject comprises human, ruminant animal, food animal, or work animal.

12. An isolated nucleic acid molecule comprising a sequence that encodes a signal peptide coupled to an encoded growth-hormone-releasing-hormone (“GHRH”) peptide, wherein the encoded signal peptide has the amino acid sequence of SEQ ID NO:51 and the encoded GHRH has the amino acid sequence of SEQ ID NO:10.

13. A method of secreting an encoded growth-hormone-releasing-hormone (“GHRH”) peptide from a cell of a subject comprising:

a. penetrating a tissue in the subject with a plurality of needle electrodes, wherein the plurality of needle electrodes are arranged in a spaced relationship;

b. introducing a single dose of an isolated nucleic acid expression construct into the tissue between the plurality of needle electrodes, wherein the single dose comprises a transfection-facilitating polypeptide; and

c. applying an electrical pulse to the plurality of needle electrodes; wherein, the isolated nucleic acid construct comprises a promoter sequence operatively linked to a sequence that encodes a signal peptide coupled to an encoded growth-hormone-releasing-hormone (“GHRH”) peptide, wherein the encoded signal peptide has the amino acid sequence of SEQ ID NO:51 and the encoded GHRH has the amino acid sequence of SEQ ID NO:10; the transfection-facilitating polypeptide comprises poly-L-glutamate; and the subject comprises human, ruminant animal, food animal, or work animal.

Assignments (2)
MERGER Recorded Feb 2, 2021
From: VGX PHARMACEUTICALS, LLC
To: INOVIO PHARMACEUTICALS, INC.
Reel/Frame 055114/0843 →
MERGER AND CHANGE OF NAME Recorded Dec 21, 2020
From: VGX PHARMACEUTICALS, INC.; INOVIO ACQUISITION, LLC
To: VGX PHARMACEUTICALS, LLC
Reel/Frame 054704/0830 →